{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:08:39Z","timestamp":1787065719310,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semradonc.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:15:21Z","timestamp":1749755721000},"page":"353-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Use of Particle Therapy in Prostate Cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Abigail","family":"Pepin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Vapiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2025.03.001_bib0001","unstructured":"Cancer of the prostate - cancer stat facts. SEER. Accessed October 4, 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, part I: Introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0003","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0360-3016(91)90020-5","article-title":"Neon ion radiotherapy: Results of the phase I\/II clinical trial","volume":"20","author":"Linstadt","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2023.12.041","article-title":"Temporal evolution and diagnostic diversification of patients receiving Proton Therapy in the United States: A ten-year trend analysis (2012 to 2021) from the National Association for Proton Therapy","volume":"119","author":"Hartsell","year":"2024","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.2990110209","article-title":"Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: Updated results of the RTOG 7704 randomized clinical trial","volume":"11","author":"Russell","year":"1987","journal-title":"The Prostate"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000421-199304000-00018","article-title":"Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial","volume":"16","author":"Laramore","year":"1993","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0360-3016(94)90140-6","article-title":"Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: Results of a randomized prospective trial","volume":"28","author":"Russell","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2025.03.001_bib0008","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2003.09.001","article-title":"Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC","volume":"58","author":"Scalliet","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0009","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1020805222151","article-title":"Fast neutron irradiation for prostate cancer","volume":"21","author":"Forman","year":"2002","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(96)00020-X","article-title":"Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer: Preliminary estimates of the therapeutic ratio","volume":"35","author":"Forman","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0011","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0360-3016(96)00136-8","article-title":"Hip stiffness following mixed conformal neutron and photon radiotherapy: A dose-volume relationship","volume":"35","author":"Chuba","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0012","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/j.ijrobp.2004.07.348","article-title":"Results of a phase III study testing the sequence of neutron irradiation in a mixed beam schedule for patients with localized prostate cancer","volume":"60","author":"Forman","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2025.03.001_bib0013","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pros.10328","article-title":"Phase I\/II clinical trials of carbon ion therapy for prostate cancer","volume":"58","author":"Akakura","year":"2004","journal-title":"The Prostate"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2006.08.015","article-title":"Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study","volume":"81","author":"Ishikawa","year":"2006","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2005.04.022","article-title":"Hypofractionated radiotherapy with carbon ion beams for prostate cancer","volume":"63","author":"Tsuji","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0016","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2012.01.072","article-title":"Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: From 20 to 16 fractions","volume":"84","author":"Okada","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-020-6570-8","article-title":"Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study \u201cGUNMA0702","volume":"20","author":"Kawamura","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0018","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2016.10.009","article-title":"A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS)","volume":"121","author":"Nomiya","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"10","key":"10.1016\/j.semradonc.2025.03.001_bib0019","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/bjc.2014.191","article-title":"Phase I\/II trial of definitive carbon ion radiotherapy for prostate cancer: Evaluation of shortening of treatment period to 3 weeks","volume":"110","author":"Nomiya","year":"2014","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.semradonc.2025.03.001_bib0020","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1111\/cas.15019","article-title":"Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancer","volume":"112","author":"Sato","year":"2021","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.semradonc.2025.03.001_bib0021","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/iju.14950","article-title":"Carbon-ion radiotherapy for urological cancers","volume":"29","author":"Ishikawa","year":"2022","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0022","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2025.03.001_bib0023","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2004.12.052","article-title":"Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy","volume":"62","author":"Vargas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.semradonc.2025.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/1097-0142(19830501)51:9<1599::AID-CNCR2820510908>3.0.CO;2-O","article-title":"Protons or megavoltage X-rays as boost therapy for patients irradiated for localized prostatic carcinoma. An early phase I\/II comparison","volume":"51","author":"Duttenhaver","year":"1983","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0360-3016(95)00063-5","article-title":"Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone","volume":"32","author":"Shipley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.semradonc.2025.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0027","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2003.10.011","article-title":"Proton therapy for prostate cancer: The initial Loma Linda University experience","volume":"59","author":"Slater","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0028","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2016.02.038","article-title":"Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0029","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ijrobp.2021.01.043","article-title":"A pooled toxicity analysis of moderately hypofractionated proton beam therapy and intensity modulated radiation therapy in early-stage prostate cancer patients","volume":"110","author":"Vapiwala","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.03.001_bib0030","article-title":"Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center","volume":"48","author":"Sosa","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.semradonc.2025.03.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110264","article-title":"Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis","volume":"195","author":"Corrao","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2025.03.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109854","article-title":"Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center","volume":"188","author":"Sosa","year":"2023","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"5","key":"10.1016\/j.semradonc.2025.03.001_bib0043","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0044","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2025.03.001_bib0046","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.euo.2018.06.013","article-title":"Phase 2 multicenter trial of heterogeneous-dosing stereotactic body radiotherapy for low- and intermediate-risk prostate cancer: 5-year outcomes","volume":"1","author":"Fuller","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0047","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1442-2042.2012.02961.x","article-title":"Carbon-ion radiation therapy for prostate cancer","volume":"19","author":"Ishikawa","year":"2012","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2019.05.069","article-title":"Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer","volume":"105","author":"Grewal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0048","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijrobp.2020.11.007","article-title":"Proton therapy for localized prostate cancer: Long-term results from a single-center experience","volume":"109","author":"Takagi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: A systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0034","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2024.08.012","article-title":"Prostate advanced radiation technologies investigating quality of life (PARTIQoL): Phase III randomized clinical trial of proton therapy vs. IMRT for localized Prostate cancer","volume":"120","author":"Efstathiou","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"10.1016\/j.semradonc.2025.03.001_bib0035","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1002\/cncr.32457","article-title":"Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting","volume":"125","author":"Santos","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semradonc.2025.03.001_bib0036","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-019-1325-x","article-title":"Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial","volume":"14","author":"Koerber","year":"2019","journal-title":"Radiat Oncol Lond Engl"},{"issue":"9","key":"10.1016\/j.semradonc.2025.03.001_bib0049","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cncr.27956","article-title":"Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer","volume":"119","author":"Gray","year":"2013","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.semradonc.2025.03.001_bib0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.28536","article-title":"Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer","volume":"120","author":"Hoppe","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0037","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urolonc.2016.06.003","article-title":"Maximizing resources in the local treatment of prostate cancer: A summary of cost-effectiveness studies","volume":"35","author":"Muralidhar","year":"2017","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0038","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41391-019-0140-7","article-title":"Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care","volume":"22","author":"Kamran","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.semradonc.2025.03.001_bib0039","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(16)00171-6","article-title":"Beyond a moonshot: Insurance coverage for proton therapy","volume":"17","author":"Shah","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.semradonc.2025.03.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10670","article-title":"Travel-time disparities in access to proton beam therapy for cancer treatment","volume":"7","author":"Burus","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semradonc.2025.03.001_bib0041","article-title":"Disparities in the utilization of radiation therapy for prostate cancer in the United States: A comprehensive review","volume":"7","author":"Gardner","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.03.001_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00031.1","article-title":"Consensus statement on proton therapy for prostate cancer","volume":"8","author":"Bryant","year":"2021","journal-title":"Int J Part Ther"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T15:05:38Z","timestamp":1750777538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429625000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1053429625000281"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.03.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Particle Therapy in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}